Can AI design better knee pain exercises?

NCT ID NCT07405034

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an artificial intelligence-driven exercise program can reduce pain and improve knee function better than conventional exercises in people with patellofemoral pain syndrome. Forty adults aged 18 to 40 with knee pain lasting at least three months will be randomly assigned to either AI-designed or standard exercises for six weeks. Researchers will measure pain, knee angle, and function before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-driven exercise program
What this could lead to
If successful, this could show that AI-designed exercises are more effective than standard therapy for reducing knee pain and improving function.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply to everyone. The AI program is not yet proven, and benefits may be similar to conventional therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATELLO FEMORAL PAIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • the out-patient clinic faculty of physical therapy, Cairo University,

    Cairo, The Capital, Egypt

  • the out-patient clinic faculty of physical therapy, Cairo University,

    Cairo, Egypt

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.